XML 43 R31.htm IDEA: XBRL DOCUMENT v3.7.0.1
Stock-Based Compensation (Tables)
 12 Months Ended
Dec. 31, 2016
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
The components of stock-based compensation expense for all of the Company’s stock-based plans
The table below summarizes the components of stock-based compensation expense for all of the Company’s stock-based plans by award type for the indicated periods:
 
 
Year ended December 31,
 
 
2016
 
2015
 
2014
 
 
 
 
 
 
 
Time-vested deferred stock
 
$
2,143

 
$
2,674

 
$
1,579

Stock appreciation rights
 
(1
)
 
11

 
148

Performance-based share awards
 
33

 
(462
)
 
664

Stock purchase plan
 
—

 
2

 
11

Stock options
 
67

 
130

 
306

Total stock-based compensation
 
$
2,242

 
$
2,355

 
$
2,708
Summary of the Company's equity activity
The following table summarizes the Company’s TVDS activity and related information for the indicated periods:
 
 
Time Vested Deferred Stock
 
Weighted-Average
Grant Date
Fair Value
 
Weighted-Average Remaining Contractual Life (in Years)
 
 
 
 
 
 
 
Outstanding non-vested as of December 31, 2013
 
379

 
$
14.69

 
 
Granted
 
378

 
14.70

 
 
Vested
 
(102
)
 
13.80

 
 
Canceled
 
(164
)
 
17.11

 
 
Outstanding non-vested as of December 31, 2014
 
491

 
15.33

 
 
Granted
 
335

 
11.70

 
 
Vested
 
(65
)
 
16.61

 
 
Canceled
 
(33
)
 
14.09

 
 
Outstanding non-vested as of December 31, 2015
 
728

 
13.60

 
 
Granted
 
598

 
6.83

 
 
Vested
 
(182
)
 
14.79

 
 
Canceled
 
(208
)
 
12.85

 
 
Outstanding non-vested as of December 31, 2016
 
936

 
9.21

 
3.1
Schedule of share equivalents
 
 
December 31,
 
 
2016
 
2015
 
2014
 
 
 
 
 
 
 
Dividend participation
 
$
176

 
$
429

 
$
217

Closing market price per share
 
$
7.40

 
$
6.76

 
$
17.71

Equivalent shares at closing market price
 
24

 
63

 
12
Summary of the Company’s SARs activity and related information
The following table summarizes the Company’s SARs activity and related information for the indicated periods:
 
 
SARs
 
Weighted-Average Exercise Price
 
Weighted-Average Remaining Contractual Life (in Years)
 
Aggregate Intrinsic Value
 
 
 
 
 
 
 
 
 
Outstanding as of December 31, 2013
 
493

 
$
15.98

 
 
 
 
Exercised
 
(60
)
 
11.26

 
 
 
 
Canceled
 
(72
)
 
12.09

 
 
 
 
Expired
 
(174
)
 
21.92

 
 
 
 
Outstanding as of December 31, 2014
 
187

 
13.47

 
 
 
 
Exercised
 
(45
)
 
11.87

 
 
 
 
Canceled
 
(20
)
 
11.09

 
 
 
 
Expired
 
(27
)
 
22.91

 
 
 
 
Outstanding as of December 31, 2015
 
95

 
12.09

 
 
 
 
Exercised
 
—

 
—

 
 
 
 
Canceled
 
(1
)
 
10.98

 
 
 
 
Expired
 
(19
)
 
10.89

 
 
 
 
Outstanding as of December 31, 2016
 
75

 
12.41

 
1.2
 
$
—

Exercisable as of December 31, 2016
 
75

 
12.41

 
1.2
 
—

Exercisable and expected to vest as of December 31, 2016
 
75

 
12.41

 
1.2
 
—
Company’s PCDS activity and related information
The following table summarizes the Company’s performance-based share awards activity and related information for the indicated periods:
 
 
Performance-Based Share Awards
 
Weighted-Average
Grant Date
Fair Value
 
Weighted-Average Remaining Contractual Life (in Years)
 
 
 
 
 
 
 
Outstanding as of December 31, 2013
 
42

 
$
17.36

 
 
Granted
 
1,607

 
15.53

 
 
Vested
 
—

 
—

 
 
Canceled
 
(45
)
 
17.66

 
 
Outstanding as of December 31, 2014
 
1,604

 
15.52

 
 
Granted
 
—

 
—

 
 
Vested
 
—

 
—

 
 
Canceled
 
(19
)
 
17.92

 
 
Outstanding as of December 31, 2015
 
1,585

 
15.49

 
 
Granted
 
151

 
5.21

 
 
Vested
 
—

 
—

 
 
Canceled
 
(154
)
 
15.96

 
 
Outstanding as of December 31, 2016
 
1,582

 
14.47

 
2.0
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions

The Company did not grant any stock options during 2016 or 2015. The following table summarizes the range of assumptions used to estimate the fair values of stock options granted for the indicated period:
 
 
Year ended December 31,
 
 
2014
 
 
 
Risk-free interest rate
 
1.10-2.03%
Expected life
 
3.8-6.0 years
Expected stock price volatility
 
50-51%
Expected dividend yield
 
2.85-3.40%
Summary of the Company’s stock option activity and related information
The following table summarizes the Company’s stock option activity and related information for the indicated periods:
 
 
Options
 
Weighted-Average Exercise Price
 
Weighted-Average Remaining Contractual Life (in Years)
 
Aggregate Intrinsic Value
 
 
 
 
 
 
 
 
 
Outstanding as of December 31, 2013
 
260

 
$
17.09

 
 
 
 
Granted
 
94

 
16.68

 
 
 
 
Exercised
 
(14
)
 
17.36

 
 
 
 
Canceled
 
(161
)
 
17.21

 
 
 
 
Outstanding as of December 31, 2014
 
179

 
16.74

 
 
 
 
Granted
 
—

 
—

 
 
 
 
Exercised
 
(23
)
 
17.13

 
 
 
 
Canceled
 
(29
)
 
17.54

 
 
 
 
Outstanding as of December 31, 2015
 
127

 
16.50

 
 
 
 
Granted
 
—

 
—

 
 
 
 
Exercised
 
—

 
—

 
 
 
 
Canceled
 
(74
)
 
15.96

 
 
 
 
Outstanding as of December 31, 2016
 
53

 
17.23

 
3.5
 
$
—